Interprofessional Care of Patients with Hyperlipidemia

To participate in this activity, please:

Log in Sign Up

Atherosclerotic cardiovascular disease (ASCVD) remains the most common cause of morbidity and mortality in the United States. Low-density lipoprotein cholesterol (LDL-C) is a key modifiable risk factor for ASCVD and the primary lipid target for most patients with hyperlipidemia. To address the varied, often complex consequences of hyperlipidemia, care provided by an interprofessional, multidisciplinary care team is necessary. This activity highlights key concepts in managing patients with hyperlipidemia, provides an overview of the principles of interprofessional collaboration, and describes recommended roles for each member of the interprofessional, multidisciplinary care team for hyperlipidemia.

Course Credit:

0.25 AAPA Category I CME Credit
0.25 ACPE Contact Hours
0.25 AMA PRA Category 1 CreditsTM
0.25 ANCC Contact Hours
0.25 CA-BRN Contact Hours

Dates:

Opens: 2026-01-16
Closes: 2027-01-16

Target Audience:

This activity was developed for nurse practitioners, pharmacists, physician associates, and physicians who provide care to patients with hyperlipidemia.

This activity was self-funded by Annenberg Center for Health Sciences.

Accreditation Information

Accreditation

In support of improving patient care, the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 0.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 hours AAPA Category 1 CME credits. Approval is valid until January 16, 2027. Physician Associates should only claim credit commensurate with the extent of their participation.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 ANCC contact hours.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 0.25 contact hours.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Additional Content Planners

James Backes, PharmD (Planner)
No significant relationships to disclose.

Melissa Ketchum, CHCP (Planner)
No significant relationships to disclose.

Gregory Scott, PharmD, RPh (Planner)
No significant relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Contributing Faculty

  • John E. Anderson, MD

    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

  • Christopher Flores, MD

    Family Medicine Physician
    Eisenhower Medical Center
    Rancho Mirage, California

  • Seth S. Martin, MD

    Director of the Advanced Lipid Disorders Program and Digital Health Lab
    Ciccarone Center for the Prevention of Cardiovascular Disease
    Professor of Medicine
    Johns Hopkins
    Baltimore, Maryland

  • LaTosha Mollette, DNP

    Family Nurse Practitioner
    Louisiana Family Medicine Clinic
    Jonesboro, Louisiana

  • Michael Smith, PharmD

    Clinical Pharmacist in Pain/Palliative Care
    University of Michigan
    Ann Arbor, Michigan

Learning Objectives

  • Describe the evolution in the treatment landscape for patients with hyperlipidemia
  • Identify strategies to improve interprofessional care of patients with hyperlipidemia

Faculty Disclosures

John E. Anderson, MD

Advisory Board: Abbott, Bayer, Corcept, Eli Lilly, Novo Nordisk, Sanofi


Christopher Flores, MD

No relationships to disclose.

Seth S. Martin, MD

Advisory Board: Care Access

Consultant: Amgen, Arrowhead, HeartFlow, Merck, New Amsterdam, Novartis, Verve Therapeutics

Ownership: Corrie Health


LaTosha Mollette, DNP

No relationships to disclose.

Michael Smith, PharmD

No relationships to disclose.